In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 5th, 2008 | 46 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.97 | 14.33 | -58.12 | 4 | 12 | 1 | 138 | 622.754 | 6 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HCK-1-E | Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1220 | 0.18 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 147 | 0.21 | Binding ≤ 10μM |
LYN-1-E | Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1180 | 0.18 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 9050 | 0.15 | Binding ≤ 10μM |
LCK-2-E | Tyrosine-protein Kinase LCK (cluster #2 Of 2), Eukaryotic | Eukaryotes | 78 | 0.22 | Functional ≤ 10μM |
Z50594-1-O | Mus Musculus (cluster #1 Of 9), Other | Other | 78 | 0.22 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 147 | 0.21 | Binding ≤ 1μM |
HCK_HUMAN | P08631 | Tyrosine-protein Kinase HCK, Human | 1220 | 0.18 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 147 | 0.21 | Binding ≤ 10μM |
LYN_HUMAN | P07948 | Tyrosine-protein Kinase Lyn, Human | 1180 | 0.18 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 9050 | 0.15 | Binding ≤ 10μM |
Z50594 | Z50594 | Mus Musculus | 78 | 0.22 | Functional ≤ 10μM |
LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 78 | 0.22 | Functional ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 80 | 0.22 | Functional ≤ 10μM |
Description | Species |
---|---|
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
Cell surface interactions at the vascular wall | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
Downstream TCR signaling | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Fc epsilon receptor (FCERI) signaling | |
FCERI mediated Ca+2 mobilization | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
FCGR activation | |
Generation of second messenger molecules | |
GPVI-mediated activation cascade | |
Growth hormone receptor signaling | |
Interleukin-2 signaling | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PIP3 activates AKT signaling | |
Platelet Adhesion to exposed collagen | |
Regulation of KIT signaling | |
Regulation of signaling by CBL | |
Role of LAT2/NTAL/LAB on calcium mobilization | |
Signaling by ERBB2 | |
Signaling by SCF-KIT | |
Translocation of ZAP-70 to Immunological synapse |
No pre-computed analogs available. Try a structural similarity search.